If you are visually impaired or blind, you can visit the PDF version by Pressing CONTROL + ALT + 4
You need a JavaScript-enabled browser to view this Publication
Please follow these steps to view the Publication:
Enable JavaScript in your browser
Refresh this page
Best regards
Zmags
Treatment Strategies - Hepatic Encephalopathy
Real-World Evidence:
Does it Really Change Clinical Practice?
Summary of Presentations from the Norgine-sponsored
Satellite Symposium at The International Liver Congress™
2015, 50th Annual Meeting of the European Association for
theStudyoftheLiver,Vienna,Austria,22nd–26thApril2015
Sara Montagnese,1* Jasmohan S. Bajaj,2 Paolo Angeli3 and Aleksander Krag4
1. Reader in Medicine and Honorary Consultant Physician, University of Padova, Padova, Italy; 2. Associate Professor of
Medicine, Virginia Commonwealth University and McGuire VA Medical Center, Richmond, VA, USA; 3. Associate Professor of
Internal Medicine, University of Padova, Padova, Italy; 4. Professor of Hepatology, University of Southern Denmark and Head of
Hepatology, Odense University Hospital, Odense, Denmark
IntroductionDr Sara Montagnese is a Reader in Medicine and
Honorary Consultan
Treatment Strategies - Hepatic Encephalopathy
Treatment Strategies - Hepatic Encephalopathy
(‘NACSELD-II’) is to identify the determinants of
Treatment Strategies - Hepatic Encephalopathy
Treatment Strategies - Hepatic Encephalopathy
Treatment Strategies - Hepatic Encephalopathy
Treatment Strategies - Hepatic Encephalopathy
Treatment Strategies - Hepatic Encephalopathy